Intra-articular injection of synovial mesenchymal stem cells improves cartilage repair in a mouse injury model

被引:0
作者
J. Mak
C. L. Jablonski
C. A. Leonard
J. F. Dunn
E. Raharjo
J. R. Matyas
J. Biernaskie
R. J. Krawetz
机构
[1] McCaig Institute for Bone & Joint Health,Department of Surgery
[2] University of Calgary,Department of Radiology
[3] University of Calgary,Department of Comparative Biology and Experimental Medicine
[4] University of Calgary,Department of Anatomy and Cell Biology
[5] Experimental Imaging Centre,undefined
[6] University of Calgary,undefined
[7] University of Calgary,undefined
[8] Alberta Children’s Hospital Research Institute,undefined
[9] University of Calgary,undefined
[10] University of Calgary,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Controversy remains whether articular cartilage has an endogenous stem/progenitor cell population, since its poor healing capacity after injury can lead to diseases such as osteoarthritis. In the joint environment there are mesenchymal stem/progenitor cells (MSCs) in the synovial membrane and synovial fluid that can differentiate into cartilage, but it is still under debate if these cells contribute to cartilage repair in vivo. In this study, we isolated a Sca-1 positive, chondrogenesis capable population of mouse synovial MSCs from C57BL6 and MRL/MpJ “super-healer” strains. Intra-articular injection of Sca-1 + GFP + synovial cells from C57BL6 or MRL/MpJ into C57BL6 mice following cartilage injury led to increased cartilage repair by 4 weeks after injury. GFP expression was detected in the injury site at 2 weeks, but not 4 weeks after injury. These results suggest that synovial stem/progenitor cells, regardless of strain background, have beneficial effects when injected into an injured joint. MSCs derived from MRL/MpJ mice did not promote an increased repair capacity compared to MSCs derived from non-healing C57BL6 controls; however, MRL/MpJ MSCs were observed within the defect area at the time points examined, while C57BL6 MSCs were not.
引用
收藏
相关论文
共 84 条
[1]  
Pittenger MF(1999)Multilineage Potential of Adult Human Mesenchymal Stem Cells Science. 284 143-147
[2]  
Zuk PA(2002)Human Adipose Tissue Is a Source of Multipotent Stem Cells Mol. Biol. Cell. 13 4279-4295
[3]  
De Bari C(2001)Multipotent Mesenchymal Stem Cells From Adult Human Synovial Membrane Arthritis Rheum. 44 1928-1942
[4]  
De Accio FD(1991) Differentiation of Bone and Hypertrophic Cartilage from Periosteal-Derived Cells Exp Cell Res. 195 492-503
[5]  
Tylzanowski P(2012)A Stem Cell–Based Approach to Cartilage Repair Science. 336 717-721
[6]  
Luyten FP(2012)Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis Mol. Biol. Rep. 39 5683-5689
[7]  
Dennis E(2013)Enhanced human bone marrow mesenchymal stem cell functions in novel 3D cartilage scaffolds with hydrogen treated multi-walled carbon nanotubes Nanotechnology. 24 365102-1541
[8]  
Bruder SP(2013)Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study Transplantation. 95 1535-295
[9]  
Lennon DP(2014)Mesenchymal stromal cells versus betamethasone can dampen disease activity in the collagen arthritis mouse model Clin. Exp. Med. 14 285-155
[10]  
Caplan AI(2003)Development of synovial joints Birth Defects Res C Embryo Today. 69 144-73